Targeting M1 muscarinic and sigma-1 receptors in Alzheimer’s disease: Reversal of pathological hallmarks and associated cognitive dysfunction in McGill-R-Thy1-APP rats

Anavex-1-1666x833.png

The 13th International Conference on Alzheimer’s and Parkinson’s Diseases, March 29 to April 2, 2017, in Vienna, Austria.


Hélène Hall, PharmD, PhD


View Presentation

1/0